211 related articles for article (PubMed ID: 25435372)
1. LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression.
Bianco S; Jangal M; Garneau D; Gévry N
Oncogene; 2015 Aug; 34(34):4509-18. PubMed ID: 25435372
[TBL] [Abstract][Full Text] [Related]
2. The orphan nuclear receptor LRH-1 and ERα activate GREB1 expression to induce breast cancer cell proliferation.
Chand AL; Wijayakumara DD; Knower KC; Herridge KA; Howard TL; Lazarus KA; Clyne CD
PLoS One; 2012; 7(2):e31593. PubMed ID: 22359603
[TBL] [Abstract][Full Text] [Related]
3. LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner.
Kramer HB; Lai CF; Patel H; Periyasamy M; Lin ML; Feller SM; Fuller-Pace FV; Meek DW; Ali S; Buluwela L
Nucleic Acids Res; 2016 Jan; 44(2):582-94. PubMed ID: 26400164
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
Konduri SD; Medisetty R; Liu W; Kaipparettu BA; Srivastava P; Brauch H; Fritz P; Swetzig WM; Gardner AE; Khan SA; Das GM
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15081-6. PubMed ID: 20696891
[TBL] [Abstract][Full Text] [Related]
5. LRH-1 governs vital transcriptional programs in endocrine-sensitive and -resistant breast cancer cells.
Bianco S; Brunelle M; Jangal M; Magnani L; Gévry N
Cancer Res; 2014 Apr; 74(7):2015-25. PubMed ID: 24520076
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.
Liao XH; Lu DL; Wang N; Liu LY; Wang Y; Li YQ; Yan TB; Sun XG; Hu P; Zhang TC
FEBS J; 2014 Feb; 281(3):927-42. PubMed ID: 24283290
[TBL] [Abstract][Full Text] [Related]
7. Role of promyelocytic leukemia zinc finger (PLZF) in cell proliferation and cyclin-dependent kinase inhibitor 1A (p21WAF/CDKN1A) gene repression.
Choi WI; Kim MY; Jeon BN; Koh DI; Yun CO; Li Y; Lee CE; Oh J; Kim K; Hur MW
J Biol Chem; 2014 Jul; 289(27):18625-40. PubMed ID: 24821727
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
[TBL] [Abstract][Full Text] [Related]
9. The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells.
Thiruchelvam PT; Lai CF; Hua H; Thomas RS; Hurtado A; Hudson W; Bayly AR; Kyle FJ; Periyasamy M; Photiou A; Spivey AC; Ortlund EA; Whitby RJ; Carroll JS; Coombes RC; Buluwela L; Ali S
Breast Cancer Res Treat; 2011 Jun; 127(2):385-96. PubMed ID: 20607599
[TBL] [Abstract][Full Text] [Related]
10. Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells.
Lai CF; Flach KD; Alexi X; Fox SP; Ottaviani S; Thiruchelvam PT; Kyle FJ; Thomas RS; Launchbury R; Hua H; Callaghan HB; Carroll JS; Charles Coombes R; Zwart W; Buluwela L; Ali S
Nucleic Acids Res; 2013 Dec; 41(22):10228-40. PubMed ID: 24049078
[TBL] [Abstract][Full Text] [Related]
11. The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene.
Annicotte JS; Chavey C; Servant N; Teyssier J; Bardin A; Licznar A; Badia E; Pujol P; Vignon F; Maudelonde T; Lazennec G; Cavailles V; Fajas L
Oncogene; 2005 Dec; 24(55):8167-75. PubMed ID: 16091743
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21
Tseng TH; Chien MH; Lin WL; Wen YC; Chow JM; Chen CK; Kuo TC; Lee WJ
Environ Toxicol; 2017 Feb; 32(2):434-444. PubMed ID: 26872304
[TBL] [Abstract][Full Text] [Related]
13. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
Lu W; Katzenellenbogen BS
Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
[TBL] [Abstract][Full Text] [Related]
14. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
15. The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion.
Chand AL; Herridge KA; Thompson EW; Clyne CD
Endocr Relat Cancer; 2010 Dec; 17(4):965-75. PubMed ID: 20817789
[TBL] [Abstract][Full Text] [Related]
16. NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.
Liu RZ; Vo TM; Jain S; Choi WS; Garcia E; Monckton EA; Mackey JR; Godbout R
J Pathol; 2019 Feb; 247(2):186-198. PubMed ID: 30350349
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function.
Liu W; Konduri SD; Bansal S; Nayak BK; Rajasekaran SA; Karuppayil SM; Rajasekaran AK; Das GM
J Biol Chem; 2006 Apr; 281(15):9837-40. PubMed ID: 16469747
[TBL] [Abstract][Full Text] [Related]
18. ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21.
Cosi I; Pellecchia A; De Lorenzo E; Torre E; Sica M; Nesi G; Notaro R; De Angioletti M
J Hematol Oncol; 2020 Aug; 13(1):112. PubMed ID: 32791988
[TBL] [Abstract][Full Text] [Related]
19. HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism.
Mottet D; Pirotte S; Lamour V; Hagedorn M; Javerzat S; Bikfalvi A; Bellahcène A; Verdin E; Castronovo V
Oncogene; 2009 Jan; 28(2):243-56. PubMed ID: 18850004
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen receptor alpha increases p21(WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells.
Margueron R; Licznar A; Lazennec G; Vignon F; Cavaillès V
J Endocrinol; 2003 Oct; 179(1):41-53. PubMed ID: 14529564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]